{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:44:48Z","timestamp":1785789888224,"version":"3.56.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1097\/01.jcp.0000140999.45053.07","type":"journal-article","created":{"date-parts":[[2004,9,7]],"date-time":"2004-09-07T19:07:06Z","timestamp":1094584026000},"page":"544-548","source":"Crossref","is-referenced-by-count":21,"title":["Evaluating the Economic Consequences of Early Antidepressant Treatment Discontinuation"],"prefix":"10.1097","volume":"24","author":[{"given":"David V.","family":"Sheehan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Eaddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Sarnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejal","family":"Vishalpura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-13-20210128","first-page":"1327","article-title":"Determinant of antidepressant treatment outcome.","volume":"6","author":"Sood","year":"2000","journal-title":"Am J Manag Care"},{"key":"R3-13-20210128","first-page":"1239","article-title":"Patterns of antidepressant use and their relation to costs of care.","volume":"2","author":"Thompson","year":"1996","journal-title":"Am J Manag Care"},{"issue":"suppl 4","key":"R4-13-20210128","first-page":"1","article-title":"Practice guideline of patients with major depressive disorder (revision).","volume":"157","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R5-13-20210128","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1345\/aph.1A254","article-title":"Discontinuing or switching selective serotonin-reuptake inhibitors.","volume":"36","author":"Bull","year":"2002","journal-title":"Ann Pharmacother"},{"issue":"3","key":"R6-13-20210128","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0149-2918(03)80113-3","article-title":"Comparison of treatment with fluvastatin extended-release 80-mg tablets and immediate-release 40-mg capsules in patients with primary hypercholesterolemia.","volume":"25","author":"Isaacsohn","year":"2003","journal-title":"Clin Ther"},{"issue":"5","key":"R7-13-20210128","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1345\/aph.1C286","article-title":"Extended-release metoprolol succinate in chronic heart failure.","volume":"37","author":"Tangeman","year":"2003","journal-title":"Ann Pharmacother"},{"issue":"12","key":"R8-13-20210128","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2165\/00002018-200225120-00004","article-title":"A benefit-risk assessment of extended-release oxybutynin.","volume":"25","author":"Michel","year":"2002","journal-title":"Drug Safety"},{"issue":"3","key":"R9-13-20210128","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000052361","article-title":"Efficacy and safety of a new prolonged release formulation of alfuzosin 10 mg once daily versus alfuzosin 2.5 mg thrice daily and placebo in patients with symptomatic benign prostatic hyperplasia.","volume":"37","author":"van Kerrebroeck","year":"2000","journal-title":"Eur Urol"},{"key":"R10-13-20210128","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4088\/JCP.v63n0707","article-title":"Efficacy and tolerance of controlled-release and immediate-release paroxetine in the treatment of depression.","volume":"63","author":"Golden","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"suppl 1","key":"R11-13-20210128","first-page":"42","article-title":"Paroxetine treatment of major depressive disorder.","volume":"37","author":"Keller","year":"2003","journal-title":"Psychopharmacol Bull"},{"issue":"suppl 1","key":"R12-13-20210128","first-page":"176","article-title":"Efficacy and tolerability of controlled-release paroxetine.","volume":"37","author":"Golden","year":"2003","journal-title":"Psychopharmacol Bull"},{"issue":"12","key":"R13-13-20210128","first-page":"22","article-title":"Time to antidepressant discontinuation: a comparison of controlled-release paroxetine and immediate-release selective serotonin reuptake inhibitors.","volume":"16","author":"Eaddy","year":"2003","journal-title":"Manag Care Interface"},{"issue":"5","key":"R15-13-20210128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"6","key":"R16-13-20210128","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"R17-13-20210128","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/(SICI)1097-0258(19990630)18:12<1517::AID-SIM132>3.0.CO;2-4","article-title":"A frailty approach for modeling diseases with variable age of onset in families: the NHLBI family heart study.","volume":"18","author":"Siegmund","year":"1999","journal-title":"Stat Med"},{"key":"R18-13-20210128","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0167-6296(98)00056-3","article-title":"On the use of survival techniques to estimate medical care costs.","volume":"18","author":"Etzioni","year":"1999","journal-title":"J Health Econ"},{"key":"R19-13-20210128","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0167-6296(98)00025-3","article-title":"The logged dependent variable, heteroscedasticity, and the retransformation problem.","volume":"17","author":"Manning","year":"1998","journal-title":"J Health Econ"},{"key":"R20-13-20210128","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-199501000-00006","article-title":"The role of the primary care physician in patient's adherence to antidepressant therapy.","volume":"33","author":"Lin","year":"1995","journal-title":"Med Care"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-200410000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:44:42Z","timestamp":1785786282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200410000-00013"}},"subtitle":["A Comparison Between Controlled-Release and Immediate-Release Paroxetine"],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jcp.0000140999.45053.07","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}